Cargando…
Renewable, recombinant antibodies to histone post-translational modifications
Variability in the quality of antibodies to histone post-translational modifications (PTMs) presents widely recognized hindrance in epigenetics research. Here, by using antibody engineering technologies we produced recombinant antibodies directed to the trimethylated lysine residues of histone H3 wi...
Autores principales: | Hattori, Takamitsu, Taft, Joseph M., Swist, Kalina M., Luo, Hao, Witt, Heather, Slattery, Matthew, Koide, Akiko, Ruthenburg, Alexander J., Krajewski, Krzysztof, Strahl, Brian D., White, Kevin P., Farnham, Peggy J., Zhao, Yingming, Koide, Shohei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828030/ https://www.ncbi.nlm.nih.gov/pubmed/23955773 http://dx.doi.org/10.1038/nmeth.2605 |
Ejemplares similares
-
Multiplex bead binding assays using off-the-shelf components and common flow cytometers
por: Hattori, Takamitsu, et al.
Publicado: (2021) -
The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognition
por: Hattori, Takamitsu, et al.
Publicado: (2020) -
Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia
por: Oury, Julien, et al.
Publicado: (2021) -
Creating MHC-Restricted Neoantigens with Covalent Inhibitors That Can Be Targeted by Immune Therapy
por: Hattori, Takamitsu, et al.
Publicado: (2023) -
Facile target validation in an animal model with intracellularly expressed monobodies
por: Gupta, Ankit, et al.
Publicado: (2018)